RxDoctor Payments Data

Michael Pan

Internal Medicine · Torrance, CANPI 1649831553

Payments from drug & device makers

$5,698in general payments, 2019–2025

Across 94 payments — averaging $60.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Medtronic$456
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$280
  • Abiomed$271
  • Amgen$267
  • E.r. Squibb & Sons, L.L.C.$248
  • plus $2K from 20 others

What the payments were for

  • Grants$1252%
  • Travel & lodging$1,28723%
  • Food & beverage$4,03971%
  • Education$1613%
  • Gifts$872%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,698 in reported general payments places this provider in the 90th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin41$35,749
EntrestoSacubitril/Valsartan12$21,356
XareltoRivaroxaban14$9,666
Rosuvastatin Calcium21$546
Ezetimibe13$540
Carvedilol44$500
Atorvastatin Calcium33$486
Metoprolol Succinate13$259
Hydralazine Hcl11$213
Spironolactone22$209
Lisinopril24$175
Furosemide28$113
Metformin Hcl15$105
Metoprolol Tartrate13$58

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$96$35,74941 claims
NovartisEntresto$138$21,35612 claims
Johnson & JohnsonXarelto$88$9,66614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 13,581 internal medicine providers in California.

Other internal medicine in Torrance

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →